45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,287
Insurances with rates
2
CPT / HCPCS codes
1,500
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9118 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $381,825 | $190,913 | — | — | 1 |
| J3316 | TRIPTORELIN PAMOATE (PEDIATRIC) 22.5 MG IM SUSPENSION | $307,875 | $153,938 | — | — | 2 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $265,914 | $132,957 | — | — | 1 |
| J7189 | COAGULATION FACTOR VIIA RECOMB 5 MG (5,000 MCG) INTRAVENOUS SOLUTION | $224,859 | $112,430 | — | — | 2 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $198,258 | $99,129 | — | — | 2 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $192,948 | $96,474 | — | — | 1 |
| J1628 | GUSELKUMAB 100 MG/ML SUBCUTANEOUS AUTO-INJECTOR | $190,150 | $95,075 | — | — | 1 |
| J1304 | TOFERSEN 100 MG/15 ML (6.7 MG/ML) INTRATHECAL SOLUTION | $188,060 | $94,030 | — | — | 1 |
| J2427 | PALIPERIDONE PALMITATE (6 MONTH) 1,092 MG/3.5 ML INTRAMUSCULAR SYRINGE | $182,644 | $91,322 | — | — | 1 |
| J0139 | ADALIMUMAB 80 MG/0.8 ML SUBCUTANEOUS PEN KIT | $180,736 | $90,368 | — | — | 2 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $168,452 | $84,226 | — | — | 1 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $155,096 | $77,548 | — | — | 1 |
| J9153 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $148,672 | $74,336 | — | — | 3 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $147,961 | $73,981 | — | — | 1 |
| J1440 | FECAL MICROBIOTA, LIVE-JSLM 150 ML RECTAL SUSPENSION ENEMA | $143,420 | $71,710 | — | — | 2 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $139,479 | $69,739 | — | — | 1 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $138,325 | $69,162 | — | — | 1 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $122,572 | $61,286 | — | — | 1 |
| J9380 | TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION | $118,705 | $59,353 | — | — | 1 |
| J7313 | FLUOCINOLONE 0.19 MG INTRAVITREAL IMPLANT | $115,720 | $57,860 | — | — | 1 |
| C9047 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT | $112,718 | $56,359 | — | — | 1 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $108,313 | $54,156 | — | — | 2 |
| J9289 | NIVOLUMAB 600 MG-HYALURONIDASE-NVHY 10,000 UNIT/5 ML SUBCUT SOLUTION | $107,524 | $53,762 | — | — | 1 |
| J8565 | GEFITINIB 250 MG TABLET | $103,704 | $51,852 | — | — | 1 |
| J9303 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION | $94,588 | $47,294 | — | — | 1 |
| J0775 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG SOLUTION FOR INJECTION | $89,962 | $44,981 | — | — | 1 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $83,942 | $41,971 | — | — | 1 |
| J1930 | LANREOTIDE 60 MG/0.2 ML SUBCUTANEOUS SYRINGE | $80,057 | $40,029 | — | — | 1 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $77,709 | $38,855 | — | — | 2 |
| J9015 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION | $76,652 | $38,326 | — | — | 1 |
| J9039 | BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION | $73,064 | $36,532 | — | — | 1 |
| J9021 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $72,259 | $36,130 | — | — | 2 |
| J0391 | ARTESUNATE 110 MG INTRAVENOUS SOLUTION | $70,727 | $35,364 | — | — | 2 |
| J0491 | ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION | $70,142 | $35,071 | — | — | 1 |
| J0517 | BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE | $68,047 | $34,023 | — | — | 1 |
| J9057 | COPANLISIB 60 MG INTRAVENOUS SOLUTION | $66,402 | $33,201 | — | — | 1 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $62,437 | $31,219 | — | — | 3 |
| J7504 | LYMPHOCYTE,ANTI-THYMO IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION | $62,065 | $31,033 | — | — | 2 |
| J2506 | PEGFILGRASTIM 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $60,505 | $30,253 | — | — | 1 |
| J0741 | CABOTEGRAVIR ER 400 MG/2 ML-RILPIVIRINE ER 600 MG/2ML IM SUSPENSION,ER | $59,519 | $29,760 | — | — | 1 |
| J0480 | BASILIXIMAB 20 MG INTRAVENOUS SOLUTION | $59,516 | $29,758 | — | — | 1 |
| J2997 | ALTEPLASE 50 MG INTRAVENOUS SOLUTION | $57,440 | $28,720 | — | — | 2 |
| J0565 | BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION | $54,758 | $27,379 | — | — | 2 |
| J7520 | SIROLIMUS 1 MG TABLET | $54,271 | $27,136 | — | — | 9 |
| J9299 | NIVOLUMAB 120 MG/12 ML INTRAVENOUS SOLUTION | $53,762 | $26,881 | — | — | 1 |
| J3110 | TERIPARATIDE 20 MCG/DOSE (560 MCG/2.24 ML) SUBCUTANEOUS PEN INJECTOR | $52,267 | $26,133 | — | — | 1 |
| Q5120 | PEGFILGRASTIM-BMEZ 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $50,072 | $25,036 | — | — | 1 |
| J9061 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION | $50,058 | $25,029 | — | — | 2 |
| Q5117 | TRASTUZUMAB-ANNS 420 MG INTRAVENOUS SOLUTION | $48,575 | $24,288 | — | — | 2 |
| J9072 | CYCLOPHOSPHAMIDE 500 MG/ML INTRAVENOUS SOLUTION | $48,326 | $24,163 | — | — | 1 |
Showing top 50 of 2,287 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.